Related by context. All words. (Click for frequent words.) 73 hypercholesterolaemia 72 HeFH 72 lipid lowering agents 71 atherogenic dyslipidemia 71 hyperphenylalaninemia HPA due 70 atherothrombotic disease 70 mixed hyperlipidemia 70 HIV HCV coinfected 70 macrovascular events 69 ATACAND 69 β blockers 69 atherosclerotic vascular disease 69 elevated triglyceride levels 69 invasive candidiasis 69 T1DM 69 aldosterone antagonist 69 Procoralan 69 atherothrombotic 68 extrapyramidal symptoms 68 serum lipid levels 68 HMG CoA reductase inhibitors 68 diabetes dyslipidemia 68 elevated triglycerides 68 BPS IC 68 LHRH antagonists 68 pyridostigmine 68 symptomatic VTE 68 hypercholesterolemia 68 lipid parameters 68 elevated LDL cholesterol 68 benazepril 68 fluvastatin 68 NNT = 68 candesartan cilexetil 67 lipid abnormalities 67 atherothrombosis 67 macrovascular disease 67 glycated hemoglobin levels 67 CTAP# Capsules 67 chronic periodontitis 67 antihypertensive drugs 67 riociguat 67 Combination therapy 67 antihypertensive therapy 67 primary hypercholesterolemia 67 pioglitazone HCl 67 nondiabetic patients 67 vWD 67 thromboembolic complications 67 BENICAR HCT 67 nicardipine 67 secondary hyperparathyroidism 67 T2DM 67 ß blockers 67 antidiabetic drugs 67 Candesartan 67 antiplatelet medications 67 dyslipidemia 67 thiazide diuretic 67 antioxidant supplementation 67 LDL cholesterol lowering 67 paroxetine Paxil 67 cinacalcet 67 fluoxetine paroxetine 67 candidemia 67 NATRECOR ® 67 onset diabetes mellitus 67 potentially modifiable 67 relapsed MM 66 colesevelam HCl 66 hyperlipidaemia 66 metformin sulfonylurea 66 AAT deficiency 66 chronic thromboembolic pulmonary 66 serum phosphate 66 overactive bladder symptoms 66 haematologic 66 subclinical atherosclerosis 66 systemic corticosteroid 66 diabetic microvascular complications 66 nonalcoholic steatohepatitis NASH 66 polyarticular 66 antiemetics 66 ACE Inhibitor 66 glycosylated hemoglobin levels 66 aldosterone antagonists 66 dyslipidemias 66 AVAPRO 66 G6PD deficiency 66 Tolvaptan 66 STRIDE PD 66 Carvedilol 66 CVD mortality 66 antiarrhythmic drug 66 tibolone 66 recurrent venous thromboembolism 66 AA Amyloidosis 66 cardiovascular morbidity 66 antidiabetic drug 66 lipid levels 66 urolithiasis 66 heterozygous familial 66 juvenile idiopathic arthritis JIA 66 teriflunomide 66 fibrate drugs 66 RAPAFLO R 66 venlafaxine Effexor 66 CIMZIA ™ 66 somatostatin analog 66 microvascular complications 66 agomelatine 66 postoperative AF 66 MADRS score 65 irbesartan 65 serum urate levels 65 haloperidol Haldol 65 morphometric vertebral fractures 65 neuropsychiatric symptoms 65 antiandrogens 65 Venous thromboembolism 65 PAOD 65 Fibrates 65 hyperglycaemia 65 hypercalciuria 65 androgen deficiency 65 Natalizumab 65 thiazolidinedione TZD 65 oxaliplatin Eloxatin 65 salmeterol fluticasone 65 Thiazolidinediones 65 bezafibrate 65 hypercalcaemia 65 Trandolapril 65 angiotensin converting enzyme inhibitor 65 NPH insulin 65 serum leptin 65 novel VDA molecule 65 hyperhomocysteinemia 65 constipation OIC 65 rosuvastatin #mg 65 pulmonary hypertension PH 65 depressive symptomatology 65 arterial hypertension 65 Sociodemographic 65 aripiprazole Abilify 65 glitazones 65 carotid IMT 65 Atomoxetine 65 lipid elevations 65 long acting bronchodilator 65 Primary IGFD 65 candesartan 65 Flu Cy 65 bronchial hyperresponsiveness 65 Relapsing remitting MS 65 Severe Primary IGFD 65 oxycodone CR 65 rosuvastatin Crestor 65 CIMZIA TM certolizumab pegol 65 protease inhibitor PI 65 Erythropoietic therapies may 65 Pioglitazone 65 Non inferiority 65 diabetic gastroparesis 65 vildagliptin 65 serum folate concentrations 65 diabetes mellitus T2DM 65 deferiprone 65 elevated ALT 65 hypertensives 65 alemtuzumab treated 65 proliferative retinopathy 65 SSc 65 plasma lipid 65 KIF6 carriers 65 SGPT 65 mycophenolate mofetil 65 sJIA 65 glycated hemoglobin HbA1c 65 paricalcitol 65 vasomotor symptoms 65 thromboprophylaxis 65 subclinical hypothyroidism 65 macroalbuminuria 65 Ramipril 65 sitaxsentan 65 oral antidiabetic medication 65 neutropenia dehydration dyspnea 65 hypertriglyceridemia 65 NSAID induced 65 ACEIs 65 apolipoprotein B 65 lipid lowering therapies 64 venous thromboembolic disease 64 aspirin clopidogrel 64 oxcarbazepine 64 liver histology 64 hyperlipidemia 64 INCB# [003] 64 autonomic dysfunction 64 thromboembolic 64 losartan Cozaar 64 daunorubicin 64 inflammatory rheumatic 64 acute myocardial infarction MI 64 antidiabetic medication 64 titrated glipizide 64 Atypical antipsychotics 64 Systemic Lupus Erythematosus 64 Juvenile Idiopathic Arthritis 64 glycosylated hemoglobin HbA1c 64 salmeterol HFA MDI 64 Doxil ® 64 Allergic Rhinitis 64 venlafaxine XR 64 primidone 64 QVAR ® 64 primary aldosteronism 64 hematopoietic cancers 64 homocysteine concentrations 64 BYETTA exenatide injection 64 amisulpride 64 thetreatment 64 triglyceride concentrations 64 aromatase inhibitors AIs 64 Telmisartan 64 atopic eczema 64 Primary Hypercholesterolemia 64 autoimmune thyroid 64 See CLINICAL PHARMACOLOGY 64 elevated fasting glucose 64 CRESTOR #mg 64 rheumatoid arthritis osteoarthritis ankylosing 64 antihypertensive agents 64 colorectal adenoma 64 angiotensin receptor blocker ARB 64 Lubiprostone 64 thrombotic events 64 symptomatic intracranial 64 diabetes mellitus 64 intracerebral haemorrhage 64 strontium ranelate 64 efalizumab 64 Helicobacter pylori eradication 64 mucosal inflammation 64 antitumor effect 64 Sjögren syndrome 64 thiazide 64 ischemic cardiomyopathy 64 tolvaptan 64 pyrexia mucositis sepsis febrile 64 diabetes mellitus DM 64 secondary amenorrhea 64 micafungin 64 oral diclofenac 64 prednisone prednisolone 64 thromboembolic disease 64 chronic HCV infection 64 baseline HbA1c 64 BENICAR 64 histologic subtype 64 atherothrombotic events 64 PROactive study 64 tricyclic antidepressant 64 oral FTY# 64 fasting triglyceride levels 64 Rheumatoid Arthritis RA 64 pimecrolimus cream 64 hepatorenal syndrome 64 erythropoietic 64 2 diabetes T2D 64 artery stenosis 64 Plaquenil 64 Aortic stenosis 64 macrovascular 64 oral antidiabetic 64 oral antidiabetic drugs 64 microangiopathy 64 hypercholesterolemic patients 64 acarbose 64 mg BID dose 64 metformin monotherapy 64 inhaled bronchodilators 64 lipid lowering therapy 64 steroid dexamethasone 64 galiximab 64 bacterial prostatitis 64 QVAR R 64 chronic immune thrombocytopenic 64 dosing frequency 64 Certolizumab pegol 64 tipranavir r 64 quetiapine Seroquel 64 Effexor venlafaxine 64 Prehypertension 64 lipid profiles 64 prostate cancer CaP 64 acute coronary syndromes ACS 64 comorbid depression 64 prucalopride 64 hypertension diabetes mellitus 64 direct thrombin inhibitors 64 tamoxifen Nolvadex ® 64 clinically meaningful reductions 64 protease inhibitors PIs 64 thyrotropin levels 64 VaD 64 plasma renin activity 64 Tracleer R 64 rheumatic diseases 64 hyperlipidemic 64 probiotic supplementation 64 antiplatelets 64 CP CPPS 64 desvenlafaxine succinate 64 GFT# 64 myeloproliferative neoplasms 64 PREZISTA r arm 64 Syncria R 64 Cognitive impairment 64 abnormal lipid 64 thiazide diuretics 64 serum urate 64 Nilotinib 64 leiomyomas 64 echocardiographic parameters 64 nonvertebral fractures 64 von Willebrand disease 64 infliximab Remicade 64 dose atorvastatin 64 blood phenylalanine Phe 64 pressure natriuresis 64 sulphonylureas 64 beclomethasone dipropionate 64 OAB symptoms 64 intravenous bisphosphonates 64 thyrotropin 64 PPAR gamma agonists 64 antidiabetic 64 diarrhea predominant irritable 64 CTEPH 64 overt nephropathy 64 AST ALT 64 recurrent miscarriage 64 Statin therapy 64 ABCB1 64 serum calcium levels 64 diabetic neuropathic pain 64 inhaled budesonide 64 MAGE A3 ASCI 64 tolterodine ER 64 cardiovascular calcification 64 pharmacologic intervention 64 atrophic gastritis 64 familial hypercholesterolemia 64 airway hyperresponsiveness 64 COPAXONE R 64 patients undergoing CABG 63 CANCIDAS 63 tocilizumab 63 conventional antipsychotics 63 isolated systolic hypertension 63 schizophrenia CIAS 63 stable angina 63 SCIg 63 pravastatin therapy 63 RE LY ® 63 systolic hypertension 63 RISPERDAL ® 63 NNRTI resistance 63 idraparinux 63 NATRECOR R 63 triglyceride lowering 63 impaired glucose metabolism 63 Subgroup analysis 63 comorbid disorders 63 ximelagatran 63 inflammatory biomarkers 63 neovascular 63 Quetiapine 63 valsartan 63 IPAH 63 pancreatic insufficiency 63 ACCORD Lipid 63 Darapladib 63 CYPHER Stent 63 rufinamide 63 serum calcium 63 ARB telmisartan 63 mixed dyslipidemia 63 IFN beta 63 grade cervical intraepithelial 63 guanfacine extended release 63 diabetes hyperlipidemia 63 lowering triglycerides 63 cardiometabolic risk 63 primary dysmenorrhoea 63 beta blockers ACE inhibitors 63 HbA 1c 63 evaluating tivozanib 63 serum IGF 63 GW# [003] 63 kidney urologic 63 CYT# potent vascular disrupting 63 Chronic Heart Failure 63 renoprotective 63 subsyndromal 63 periprocedural MI 63 antithrombotics 63 neurological manifestations 63 IOP lowering 63 psoriatic arthritis PsA 63 abdominal adiposity 63 metastatic neuroendocrine tumors 63 SSRI SNRI 63 thrombocytopenic 63 clomipramine 63 paroxetine sertraline 63 laboratory abnormalities 63 trastuzumab Herceptin ® 63 BMPR2 63 myopathy rhabdomyolysis 63 serum PTH 63 coinfected patients 63 biologic DMARD 63 angiotensin converting enzyme inhibitors 63 exploratory endpoints 63 tumor necrosis 63 inhaled corticosteroid therapy 63 toenail onychomycosis 63 serum uric acid 63 adjunctive placebo 63 nephrotoxicity 63 glucose lowering 63 sertraline Zoloft 63 eprotirome 63 Myelodysplastic syndromes MDS 63 ACTOS ® 63 Sitagliptin 63 Critical Limb Ischemia CLI 63 plasma homocysteine 63 bosentan 63 olmesartan 63 DDP# 63 hypercalcemia 63 mGluR5 NAM 63 C1 INH deficiency 63 angiotensin II receptor blockers 63 metaglidasen 63 non valvular atrial 63 angiotensin receptor blockers 63 TMP SMX 63 thalidomide Thalomid 63 Uncontrolled hypertension 63 glucocorticoid induced osteoporosis 63 null responder 63 dual endothelin receptor antagonist 63 AGHD 63 ziprasidone Geodon 63 6R BH4 63 comorbid anxiety 63 FOSRENOL ® 63 induce orthostatic hypotension 63 flutamide 63 atorvastatin #mg 63 elevated serum creatinine 63 neovascular diseases 63 poor metabolizers 63 allogeneic HSCT 63 atopic asthma 63 hypovitaminosis D 63 hepatic fibrosis 63 beta carotene supplementation 63 antiepileptics 63 carotid stenosis 63 neonatal morbidity 63 Ophena TM 63 transaminase elevations 63 Chemotherapy induced 63 intact parathyroid hormone 63 pharmacodynamic properties 63 vitamin D inadequacy 63 Heavy menstrual bleeding 63 Intravenous immunoglobulin 63 Subgroup analyzes 63 RoACTEMRA 63 hypocalcaemia 63 Hepatotoxicity 63 contrast induced nephropathy 63 eosinophilic asthma 63 GH deficiency 63 MULTAQ 63 COPD exacerbations 63 Dapagliflozin 63 proliferative diabetic retinopathy 63 delta gamma agonist 63 tiagabine 63 COPD exacerbation 63 comorbid conditions 63 neutrophil counts 63 knee osteoarthritis OA 63 serum retinol 63 K ras mutations 63 thrombophilia 63 dose cytarabine 63 acitretin 63 nonpharmacologic 63 posaconazole 63 Hp2 2 63 statins cholesterol lowering 63 pulmonary arterial hypertension PAH 63 Mitoxantrone 63 oesophageal adenocarcinoma 63 Glypromate 63 metabolic parameters 63 serum estradiol 63 nonischemic 63 pentoxifylline 63 Atopic 63 antimuscarinic 63 metastatic malignant 63 lipid lowering drugs 63 bexarotene 63 somatoform disorders 63 variceal bleeding 63 serum phosphate levels 63 tranylcypromine 63 Degarelix 63 arterial thickening 63 HuLuc# 63 attention-deficit/hyperactivity disorder ADHD 63 myeloproliferative diseases 63 lenalidomide dexamethasone 63 plasma lipids 63 macrolide antibiotic 63 dysfunctional voiding 63 risperidone Risperdal 63 dyslipidemic 63 ezetimibe Zetia 63 autoantibody positive 63 nadolol 63 alendronate Fosamax 63 Pemetrexed 63 Hyperlipidemia 63 rheumatic disease 63 Selective serotonin reuptake inhibitors 63 Paxil paroxetine 63 antithrombotic agents 63 solifenacin 63 pharmacodynamic parameters 63 chronic idiopathic urticaria 63 receptor inhibitor 63 nabilone 63 valsartan amlodipine 63 systolic dysfunction 63 cisplatin gemcitabine 63 affective psychosis 63 ezetimibe simvastatin 63 benign prostatic hypertrophy BPH 63 PREZISTA r 63 serum creatinine levels 63 chronic HBV infection 63 DULERA 63 vasodilators 63 albumin excretion 63 nonvertebral fracture 63 Moxifloxacin 63 demonstrated antitumor activity 63 Alzheimer disease vascular dementia 63 psychiatric comorbidities 63 chorioamnionitis 63 overactive bladder syndrome 63 fluticasone salmeterol 63 Ranolazine 63 Insulin detemir 63 antithrombotic 63 pioglitazone hydrochloride 63 memantine Namenda 63 rFVIIa 63 potassium sparing diuretics 63 gestational hypertension 63 HbA1C levels 63 Valdoxan 63 REMINYL ® 63 alfuzosin 63 pramlintide metreleptin combination 63 everolimus eluting stents 63 beta blocker atenolol 63 dose statin therapy 63 inhaled glucocorticoids 63 prospective multicentre 63 tumor histology 63 HoFH 63 sulodexide 63 folinic acid 62 Inhaled corticosteroids 62 SHPT 62 statin monotherapy 62 Calcium intake 62 diabetic kidney 62 divalproex sodium 62 CIPN 62 primary hyperparathyroidism 62 serum triglycerides 62 juvenile idiopathic arthritis 62 umol L 62 CIMZIA R 62 multivessel disease 62 inhibitor RG# 62 either acutely decompensated 62 cytopenias 62 recurrent genital herpes 62 recurrent glioblastoma multiforme 62 enalapril 62 angiotensin receptor blockers ARBs 62 renal toxicity 62 TEAEs 62 BEXXAR Therapeutic Regimen 62 bioavailable testosterone 62 HER2 expression 62 tamsulosin 62 lupus scleroderma 62 TREDAPTIVE 62 PEGylated anti 62 angiotensin II receptor blocker 62 AGGRASTAT ® tirofiban hydrochloride 62 atypical antipsychotic medications 62 stavudine d4T 62 hydroxymethyl coenzyme 62 Lipodystrophy 62 thrombotic complications 62 Kuvan sapropterin dihydrochloride 62 elevated IOP 62 angina myocardial infarction 62 pharmacokinetic interactions 62 clevidipine 62 venous thromboembolic events 62 interferon alfa 2b 62 advanced hepatocellular carcinoma 62 esophagogastric 62 Cardiotoxicity 62 refractory AML 62 Topiramate 62 dysglycemia 62 Teriparatide 62 unipolar depression 62 cilostazol 62 Diabetic nephropathy 62 plasma lipoprotein 62 sUA 62 plasma triglycerides 62 Primary endpoints 62 bronchopulmonary dysplasia BPD 62 ruboxistaurin 62 colesevelam 62 Hb A1C 62 HBeAg negative 62 ACTEMRA TM 62 NSAID induced GI 62 Secondary efficacy endpoints 62 ARCOXIA 62 muraglitazar 62 PLX STROKE targeting 62 TOVIAZ 62 baseline LDH 62 Endothelial dysfunction 62 FRAGMIN 62 APTIVUS r 62 adalimumab Humira 62 nitrofurantoin 62 neutropenia thrombocytopenia 62 serum lipids 62 lipohypertrophy 62 vesicoureteral reflux 62 chlamydial infection 62 oral antidiabetes drugs 62 haemorrhagic stroke 62 anticoagulant warfarin 62 eplerenone 62 euvolemic 62 unstable angina pectoris 62 idiopathic myelofibrosis 62 hyperprolactinemia 62 insulin glulisine 62 SORT OUT III 62 atherosclerotic disease 62 Ivabradine 62 antihypertensive medications 62 MGd 62 epoprostenol 62 serum phosphorous 62 pegylated liposomal doxorubicin 62 VAPRISOL 62 goserelin 62 β blocker 62 sorafenib Nexavar 62 esomeprazole Nexium 62 gliclazide 62 clobazam 62 atorvastatin Lipitor 62 Dasatinib 62 antiplatelet therapies 62 adrenal suppression 62 Nonalcoholic fatty liver 62 systemic lupus erythematosus SLE 62 CYP#D# inhibitor 62 ® pioglitazone HCl 62 obesity insulin resistance 62 sargramostim 62 Glatiramer acetate 62 nasopharyngitis headache 62 NIASPAN 62 trials RCTs 62 LV dysfunction 62 postmenopausal osteoporotic women 62 reuptake inhibitor 62 leucopenia 62 corrected QT interval 62 hematologic toxicity 62 antiplatelet drugs 62 VTE prophylaxis 62 Aliskiren 62 HIV seropositive 62 microvascular disease 62 fasting glucose levels 62 NMDA antagonists 62 Systemic Lupus Erythematosus SLE 62 Vaprisol 62 lipid lowering medications 62 Warfarin Coumadin 62 LDL lowering 62 HER2 overexpression 62 Elocalcitol 62 DVT PE 62 acute mania 62 comorbid psychiatric disorders 62 plasma pharmacokinetics 62 abnormal glucose tolerance 62 APTIVUS ritonavir 62 neurocognitive impairment 62 invasive aspergillosis 62 lipid lowering medication 62 serum BDNF 62 glatiramer 62 pitavastatin 62 headache nasopharyngitis 62 complete cytogenetic response 62 antiretroviral naive 62 virological response 62 cardioprotective effects 62 Atherosclerotic 62 Haptoglobin 62 Navelbine 62 Chronic HCV 62 postoperative atrial fibrillation 62 polytherapy 62 myocardial ischaemia 62 mild renal insufficiency 62 lomitapide 62 serum lipid 62 xanthine oxidase inhibitor 62 castrate resistant prostate cancer 62 chlorthalidone 62 antiangiogenic therapy 62 Heterozygous Familial Hypercholesterolemia 62 Toxicities 62 Major depressive disorder 62 prasterone 62 Tocilizumab 62 oral Hycamtin 62 diabetic dyslipidemia 62 Non Alcoholic Fatty 62 adverse reactions ≥ 62 HIV coinfected 62 serologically active patients 62 external genital lesions 62 abnormal lipids 62 congenital toxoplasmosis 62 zoledronate 62 ziconotide 62 HRQL 62 Pitavastatin 62 Raptiva r 62 intravascular hemolysis 62 triacylglycerol concentrations 62 hyperkalemia 62 #mg/day [001] 62 cardioprotection 62 hypoperfusion 62 fragility fractures 62 ischemic cardiovascular 62 recurrent acute pancreatitis 62 citalopram Celexa 62 androgen excess 62 thiazolidinediones TZDs 62 del 5q MDS 62 diastolic blood pressures 62 torsade de pointes 62 prognostic variables 62 proteinuria 62 schizophrenia schizoaffective disorder 62 MetS 62 ivabradine 62 aminotransferases 62 hormone therapy estrogen 62 MCyR 62 folate deficiency 62 recurrent DVT 62 DFMO 62 TNF alpha inhibitor 62 ULORIC 62 hemoglobin A1c HbA1c 62 AGILECT ® 62 glatiramer acetate 62 occlusive disease 62 Fondaparinux 62 platelet inhibition 62 Atacand 62 insulin sensitizing 62 abacavir Ziagen 62 ARIXTRA 62 Hyperphosphatemia 62 corticosteroid therapy 62 Mycophenolate Mofetil 62 Infusion Reactions Severe 62 #mg doses [002] 62 ALI ARDS 62 Attention-Deficit/Hyperactivity Disorder ADHD 62 recurrent VTE 62 CC genotype 62 acromegalic patients 62 chronic idiopathic thrombocytopenic purpura 62 Fingolimod 62 retinal vein occlusion induced 62 beta blocker therapy 62 smoldering multiple myeloma 62 pulmonary exacerbations 62 zonisamide SR 62 serum vitamin D 62 refractory gout 62 SNRI 62 relapsed ALL 62 Avandia Actos 62 Dyslipidemia 62 insulin detemir 62 pharmacologic treatments 62 urinary incontinence UI 62 prenatal exposures 62 interleukin IL -6 62 mitochondrial toxicity 62 perimenopausal women 62 insulin resistance syndrome 62 nonalcoholic steatohepatitis 62 pediatric bipolar disorder 62 Drospirenone 62 Bosentan 62 cardiac repolarization 62 tricyclic antidepressants 62 Silodosin 62 rosiglitazone maleate 62 primary generalized tonic 62 CETP inhibition 62 intracranial hemorrhage ICH 62 complement inhibitor eculizumab 62 alpha interferons 62 endometrial hyperplasia 62 NYHA functional class 62 Adjuvant chemotherapy 62 IGFBP 3 62 lupus nephritis 62 visilizumab 62 thrombocytopenic patients 62 neurogenic bladder 62 carotid plaque 62 glomerular filtration 62 carotid artery intima media 62 EFFEXOR XR 62 Glimepiride 62 Zestra R 62 AVODART 62 thromboembolism 62 postoperative pulmonary 62 INVEGA ® 62 calcium antagonists 62 Monopril 62 renovascular hypertension 62 improves glycemic 62 tipranavir 62 Febrile neutropenia 62 hepatic insufficiency 62 deletion 5q 62 Avanafil 62 sustained virological response 62 immunomodulation 62 KRAS mutations occur 62 thrombo embolic 62 cryptogenic 62 Exacerbations 61 VIIBRYD 61 mcg BID 61 arterial thrombosis 61 Lipitor #mg 61 definite stent thrombosis 61 Azacitidine 61 calcium supplementation 61 coagulopathy 61 ritonavir boosted 61 antithrombotic therapy 61 PCWP 61 risedronate Actonel 61 GnRH agonists 61 myocardial fibrosis 61 Lamotrigine 61 conventional DMARDs 61 Detrol Detrol LA 61 OMNARIS HFA 61 Torsades de Pointes 61 atypical neuroleptics 61 postoperative chemotherapy 61 cranial irradiation 61 purpura ITP 61 Atacand ® 61 newer atypical antipsychotics 61 abacavir lamivudine 61 hypervascular tumors 61 acetabular dysplasia 61 leukotriene receptor antagonists 61 non cirrhotic portal 61 glucocorticoid therapy 61 tigecycline 61 immunosuppressive therapies 61 Telithromycin 61 AEGR 61 adalimumab 61 immunomodulatory agents 61 anti angiogenic agents 61 colorectal liver metastases 61 trandolapril 61 preoperative chemotherapy 61 Zoloft sertraline 61 hepatic cirrhosis 61 Tasimelteon 61 chronic prostatitis 61 antiarrhythmic drugs 61 pathophysiological mechanisms 61 escitalopram Lexapro 61 metformin HCl 61 elevated CRP 61 hsCRP levels 61 prolactin levels 61 IgG1 antibodies 61 milrinone 61 SSRI citalopram 61 diabetes mellitus hypertension 61 subclinical hyperthyroidism 61 poststroke depression 61 hemorrhagic complications 61 pharmacodynamic endpoints 61 partial onset seizures 61 Non Alcoholic Steatohepatitis 61 Teriflunomide 61 pregabalin Lyrica 61 somatostatin analogs 61 Fulvestrant 61 retrospective cohort 61 skeletal metastases 61 Serdolect 61 serum cholesterol 61 Oral Fingolimod 61 HbA 1c levels 61 headache abdominal pain 61 adrenal function 61 chromium supplementation 61 albumin excretion rate 61 Testosterone deficiency 61 Myelodysplastic Syndrome MDS 61 PRADAXA #mg 61 progressive dyspnea 61 polyp recurrence 61 Aceon 61 uncontrolled hypertension 61 persistent pulmonary hypertension 61 biphasic insulin aspart 61 variant angina 61 hyperalgesia 61 HMG CoA reductase inhibitor 61 CaPre TM 61 paroxysmal AF 61 cardiovascular disease hypertension 61 painful diabetic neuropathy 61 ADPKD 61 antiplatelet agents 61 Diabetes mellitus 61 generalized anxiety disorder GAD 61 fluoxetine Prozac 61 basal bolus regimen 61 vidofludimus 61 atherosclerotic progression 61 pramlintide